Thursday, 05 August 2021 02:08 GMT

4 Covid Vaccine Candidates In Human Trial Stage, Centre Tells Rajya Sabha


(MENAFN - Trend News Agency ) Four COVID-19 vaccine candidates are at different stages of human trials while one, developed by Genique Life Sciences, is in the advanced pre-clinical stage, Union Science and Technology Minister Jitendra Singh said on Tuesday.

In a written response to a question in the Rajya Sabha, Mr Singh said Cadila Healthcare Ltd's DNA-based vaccine candidate is in phase three clinical trial. It has also submitted the interim data for emergency use authorisation.

Biological E Ltd's vaccine candidate is also in phase three clinical trial.

Bharat Biotech International Ltd's Adeno intranasal vaccine candidate is in phase three clinical trial, while Gennova Biopharmaceuticals Ltd's mRNA-vaccine candidate is in Phase one clinical trial.

The Gurgaon-based Genique Life Sciences Pvt Ltd's vaccine candidate is in the advanced pre-clinical stage, Singh said.

Currently, three vaccines --- Serum Institute of India's Covishield, Bharat Biotech's Covaxin and Russian vaccine Sputnik V --- are being administered in India.

Mr Singh said "Mission COVID Suraksha -- the Indian COVID-19 Vaccine Development Mission" was announced as part of the third stimulus package "Atmanirbhar Bharat 3.0' for promoting research and development of Indian COVID-19 vaccines.

MENAFN22072021000187011040ID1102492840


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Smart Facilities Management Conference & Showcase